Key result
Adding the 30-s chair stand test to standard risk factors improves postoperative pulmonary complication prediction.
Why the study?
Postoperative pulmonary complications after esophageal cancer surgery remain a major concern, and the clinical use of practical exercise capacity predictors such as the 30-s chair stand test and 6-min walk test needed evaluation.
Does the 30-s chair stand test or 6-min walk test predict postoperative pulmonary complications in patients with esophageal cancer?
Cohort (n=213)
Yes
Does the 30-s chair stand test or 6-min walk test predict postoperative pulmonary complications in patients with esophageal cancer?
The 30-s chair stand test is a feasible and effective predictor of postoperative pulmonary complications in patients undergoing esophageal cancer surgery.
Answers are grounded in this paper and cite their sources.
May support CS-30 for preoperative risk stratification in esophageal cancer; hypothesis-generating and requires prospective validation before practice change.
Background Postoperative pulmonary complications (PPCs) after esophageal cancer surgery remain a major concern. Preoperative exercise capacity has emerged as an important predictor. This study examined the clinical use of practical predictors—the 30-s chair stand test (CS-30) and the 6-min walk test (6MWT). Methods We retrospectively analyzed patients with esophageal cancer from three institutions who underwent preoperative physical therapy between July 2021 and June 2023. Data completeness for the CS-30 and 6MWT was compared using McNemar’s test. Three logistic regression models predicting PPCs were developed: Model 1 (established risk factors), Model 2 (risk factors plus CS-30), and Model 3 (risk factors plus 6MWT). PPCs were defined as pneumonia or sputum retention requiring intervention (Clavien–Dindo grade ≥ 2). Model performance was evaluated using the area under the curve (AUC), and incremental predictive value was assessed using net reclassification improvement (NRI) and integrated discrimination improvement (IDI). Results Among 213 patients (median age 68 years; 83% male), PPCs occurred in 57 (26.8%). Data completeness was significantly higher for the CS-30 (195/213, 91.5%) than the 6MWT (178/213, 83.6%; p < 0.001). The AUCs (95% confidence interval) were 0.775 (0.708–0.842) for Model 1, 0.786 (0.716–0.857) for Model 2, and 0.779 (0.712–0.846) for Model 3. NRI and IDI analyses showed that adding the CS-30 significantly improved reclassification and discrimination abilities. Conclusions The CS-30 was more feasible than the 6MWT and significantly improved PPCs prediction. A perioperative management model for high-risk patients based on the CS-30 is recommended.
No takes yet. Share an insight, caveat, or question.
Ikeda et al. (2026) conducted a cohort in Esophageal cancer (n=213). 30-s chair stand test (CS-30) vs. Established clinical risk factors alone was evaluated on Prediction of postoperative pulmonary complications (PPCs) (NRI 0.427, 95% CI 0.134-0.719, p=0.004). Adding the 30-s chair stand test to established clinical risk factors significantly improved the prediction of postoperative pulmonary complications (NRI 0.427, p=0.004) in patients with esophageal cancer.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: